MaxCyte, Inc. - Common Stock — 四半期キャッシュフロー (NASDAQ:MXCT) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 239.47 M229.96 M219.75 M213.48 M202.51 M194.47 M 負債合計 33.22 M30.55 M29.03 M33.2 M31.02 M26.59 M 純資産合計 206.25 M199.41 M190.72 M180.28 M171.49 M167.89 M 負債および純資産合計 239.47 M229.96 M219.75 M213.48 M202.51 M194.47 M 有利子負債合計 —————— 純負債 ——————

ニュース

Stock Market Today: Dow Jones Futures Fall, S&P 500 Gains As Trump Takes Big Tech Leaders To China—Nvidia

水曜日に注目すべき株式：シスコ、アリババ、ネクストパワー、および2つの銘柄

MaxCyte, Inc. (MXCT) Q1 2026 Earnings Call Transcript

MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates

MaxCyte, Inc. (MXCT) Q4 2025 Earnings Call Transcript

MaxCyte, Inc. (MXCT) Reports Q4 Loss, Misses Revenue Estimates

Cellares appoints Ali Soleymannezhad as chief commercial officer

MaxCyte, Inc. (MXCT) Q3 2025 Earnings Call Transcript

MaxCyte CFO Douglas Swirsky to step down in first half of 2026

Avidity Biosciences, Inc. (RNA) Reports Q3 Loss, Beats Revenue Estimates

ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Beat Estimates

Masoud Maher buys Maxcyte (MXCT) shares worth $102,915